Cancer Nursing Professorial Precinct, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Cancer Nursing Professorial Precinct, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; Redcliffe Hospital, Brisbane, Queensland, Australia.
Infect Dis Health. 2023 Nov;28(4):298-307. doi: 10.1016/j.idh.2023.05.005. Epub 2023 Jul 5.
Patients require vascular access for medical treatments, diagnostic procedures and symptom management. Current failure rates of peripheral intravascular catheters (PIVCs) are unacceptably high (40-50%). This systematic review aimed to determine the effect of different PIVC materials and designs on the incidence of PIVC failure.
A systematic search was conducted in November 2022 using CINAHL, PubMed, EMBASE and Cochrane Central Register of Controlled Trials databases. Randomised controlled trials that compared PIVC novel PIVC material/design and standard material/design were included. The primary outcome was all causes of PIVC failure, any reason for device removal due to cessation of device function; and secondary outcomes included individual PIVC complications and infection (local or systemic), and dwell times. Quality appraisal was conducted using the Cochrane risk of bias tool. A meta-analysis was performed using random effects model.
Seven randomised controlled trials were eligible for inclusion. In meta-analysis, the impact of material and design on PIVC failure in the studies favoured the intervention arms (RR 0.71, 95% CI 0.57-0.89), however there was substantial heterogeneity (I = 81%, 95% CI 61-91%). Through subgroup analyses, a significant difference on PIVC failure favoured the closed system over the open system (RR 0.85, 95% CI 0.73 to 0.99; I = 23%, 95% CI 0-90%).
Catheter material and design can impact PIVC outcome. Conclusive recommendations are limited due to the small number of studies and inconsistent reporting of clinical outcomes. Further rigorous research of PIVC types is necessary to improve clinical practice and device selection pathways should reflect the resulting evidence.
患者需要血管通路进行医疗治疗、诊断程序和症状管理。目前,外周血管内导管(PIVC)的失败率高得令人无法接受(40-50%)。本系统评价旨在确定不同的 PIVC 材料和设计对 PIVC 失败发生率的影响。
2022 年 11 月,我们在 CINAHL、PubMed、EMBASE 和 Cochrane 对照试验中心注册数据库中进行了系统搜索。纳入了比较 PIVC 新型 PIVC 材料/设计与标准材料/设计的随机对照试验。主要结局是所有 PIVC 失败原因、因器械功能停止而因任何原因移除器械;次要结局包括单个 PIVC 并发症和感染(局部或全身)以及留置时间。使用 Cochrane 偏倚风险工具进行质量评估。使用随机效应模型进行荟萃分析。
有 7 项随机对照试验符合纳入标准。荟萃分析中,材料和设计对研究中 PIVC 失败的影响偏向于干预组(RR 0.71,95%CI 0.57-0.89),但存在很大的异质性(I=81%,95%CI 61-91%)。通过亚组分析,封闭系统在 PIVC 失败方面明显优于开放系统(RR 0.85,95%CI 0.73 至 0.99;I=23%,95%CI 0-90%)。
导管材料和设计会影响 PIVC 结果。由于研究数量少且临床结局报告不一致,因此无法得出明确的结论。需要进一步对 PIVC 类型进行严格的研究,以改善临床实践,选择路径应反映出由此产生的证据。